Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (5039)	8/20/1998 6:53:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Viagra Poised for EU Approval Next Week, La Libre Belgique Says Brussels, Aug. 20 (Bloomberg) -- European Union regulators are expected to approve Pfizer Inc.'s Viagra impotence pill for sale in the 15-nation EU in the next nine days, La Libre Belgique reported, without citing sources. The ruling comes after the European Medicines Evaluation Agency, an expert panel that advises European regulators on drug approvals, gave the drug its backing in May. The drug will go on sale at different times in EU countries, depending on how long governments take to set prices; French pharmacies will be able to start selling Viagra in October, while Belgian pharmacies are expected to begin carrying it in December, the paper said. EU residents have been traveling to buy Viagra in pharmacies in Andorra and Switzerland since it became one of the best-selling U.S. drugs following its introduction in April. (La Libre Belgique 8/20, 1) quote.bloomberg.com